Essen, Germany-based speciality chemicals company Evonik Industries has announced its full year financial results for 2015, stating it saw its sales rise by 5 percent compared to 2014, up from 12.9 billion euros ($14.1 billion) to 13.5 billion euros ($14.6 billion).
The company's EBITDA for 2015 was 2.47 billion euros ($2.7 billion), up 31 percent from 2014.
Klaus Engel, Chairman of the Executive Board of Evonik Industries said: “Our strategy of investing vigorously in organic growth, in other words, in new production capacities and innovations, has paid off for the company and its shareholders. Thanks to our understanding of our customers' specific requirements, we were once again able to provide them with tailor-made products and solutions.”
Looking at the year ahead Engel said: “Although the global business environment deteriorated further at the turn of the year, we will continue to utilize growth opportunities systematically in 2016.”
Evonik says it sees Greater China as one of the driving forces of the global economy and aims to grow in that region. The company currently has 3,000 employees in the Greater China region and reports regional sales of over 1.3 billion euros ($1.4 billion) in 2015.
Evonik is present in more than 100 countries worldwide and has more than 33,500 employees.